Fundraising Fox

Aristea Therapeutics

San Diego, US · Founded 2018 · Delaware corporation · 5 known investors

Biotech

Founders & leadership

JM
James MackayExecutive

Board

LT
Loretta TseBoard director
KH
Kenneth HarrisonBoard directorInvestor at Novo Holdings
TATiba Aynechi
Tiba AynechiinMember Board Of Directors2018–2021General Partner at Norwest Venture Partners
CK
Ciara KennedyBoard director

Investors · 5

Fidelity Investmentsreported · 2 sourcesBoston
Norwest Venture PartnersreportedMenlo Park · $10M – $30Mvia Tiba Aynechi · board
Novo Holdingsreported · 2 sourcesCopenhagen · $1.1M – $54M

Also in the syndicate · 2

Arena PharmaceuticalsTekla Capital Management, LLC

Funding

SEC filings, press & company announcements

$126.1M disclosed across 2 rounds · 2020–2021

▶$63.1MraisedAug 2021 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Loretta TseDirector
  • James MackayExecutive Officer, Director
  • Kenneth HarrisonDirector
  • Tiba AynechiDirector
  • Ciara KennedyDirector
Offering amount
$63.1M
Amount sold
$63.1M
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Wider Arena: Aristea Pursues Excellence with $123M in Investmentgenengnews.com · Aug 2021Aristea Completes $63 Million Series B Financing to Accelerate Clinical Development of Novel Immunotherapy Drugs for the Treatment of Orphan Diseasesprnewswire.com · Jul 2021Aristea Therapeutics Closes $63M Series B Financingfinsmes.com · Jul 2021San Diego California based Aristea Therapeutics is raising $62,620,986.00 in New Equity Investment. - intelligence360intelligence360.news · Nov 2020Aristea Therapeutics Launches with Phase 2 Drug Candidate and $15M in Series A Funding from Novo Holdings A/Sprnewswire.com · Dec 2018Aristea Therapeutics Raises $15M in Series A Funding - FinSMEsfinsmes.com · Dec 2018

Frequently asked questions

Who are Aristea Therapeutics's investors?
Aristea Therapeutics's investors include Fidelity Investments, Norwest Venture Partners, Novo Holdings.
How much funding has Aristea Therapeutics raised?
Aristea Therapeutics has disclosed $126.1M raised across 2 rounds.
Where is Aristea Therapeutics headquartered?
Aristea Therapeutics is headquartered in San Diego, US.